In early March 2022, the National Alliance for Direct Support Professionals (NADSP) embarked on its first ever national advocacy event, the 2022 Advocacy Symposium, Amplifying The Voices Of Direct Support Professionals (DSPs). Attendees participated in over 250 meetings with legislative staff to share the perspective of direct support professionals to the forefront of Congress during a time of unprecedented workforce challenges. The result of our attendees’ advocacy culminated in additional sponsors to the House of Representatives and US Senate bills regarding establishing a Standard Occupation Classification within the Bureau of Statistics for direct support professionals (S. 1437 / H.R. 4779).
NADSP is excited to announce the return of the Advocacy Symposium on May 3 – 4, 2023! Ahead of this two-day virtual event, attendees will receive comprehensive advocacy training along with planning sessions with state leaders. The success of our first Advocacy Symposium is directly a result of and informed by the people who are on the frontlines of supporting people with disabilities to live, work, and thrive in the community.
We’re looking forward to amplifying even more direct support professional voices in 2023. This event is free and open to direct support professionals, frontline supervisors, self-advocates, family members, and people with disabilities. Registration for this event will open on February 28.
NADSP’s Current 2023 Policy Priorities:
With the passage and signing into law of a federal omnibus appropriations bill last week, the requirement that healthcare providers possess a Drug Enforcement Administration (DEA) X-waiver to prescribe buprenorphine to treat opioid use disorder (OUD) has been eliminated. The move is intended to expand access to addiction treatment.
Named for the “x” that accompanies a narcotics prescribing license, DEA X-waivers have been required to prescribe buprenorphine, a Schedule III drug, as treatment for OUD. Applying for an X-waiver required providers to undergo additional training. The X‑waiver requirement had also limited the number of patients providers can treat. It was largely seen as a barrier preventing many practitioners from treating addiction.
Read the White House’s statement on elimination of the X-waiver.
Treasurer Stacy Garrity and disability advocates across Pennsylvania hail Congress’s passage of the ABLE Age Adjustment Act, which will expand ABLE program eligibility to include an estimated 6 million more Americans, including one million veterans, by raising the age limit for onset of a disability from 26 to 46 starting in 2026. ABLE accounts are a tax-free way to save for disability-related expenses while maintaining means-tested government benefits.